Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid

Kander Elizabeth M; Shah Manisha H; Zhou Ye; Goyal Ashima; Palmer Joshua D; Owen Dwight H; Shilo Konstantin; Patel Gopal; Raval Raju R; Gonzalez Javier; Nguyen Michele; Olek Elizabeth; Kherani Jennifer; Rothenberg S Michael; Konda Bhavana

Clinical Lung Cancer 2021